Keywords: smithkline, beecham, hycamtin, receives, eu, approval, topotecan

SmithKline Beecham's Hycamtin Receives EU Approval

Article | 25 November 1996

- SmithKline Beecham's Hycamtin (topotecan) has been granted marketing clearance in all 15 European Union member states for the second-line treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Hycamtin

Topotecan Hydrochloride

Paclitaxel

Taxol

Go to drug listing